Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $1.2791 is 3.99% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 1.4599||$ 4.77|
|Low:||$ 1.25||$ 1.23|
ETFs with NOVN as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|13.48%||iShares Inc iShares MSCI Switzerland ETF (EWL)||-1.41 (-4.15%)|
|4.46%||iShares Global Healthcare ETF (IXJ)||+1.66 (2.82%)|
|4.36%||iShares Edge MSCI Intl Momentum Factor ETF (IMTM)||-3.21 (-10.69%)|
|3.4%||iShares Trust (IGRO)||-5.41 (-9.64%)|
|2.84%||iShares Europe ETF (IEV)||-5.08 (-11.15%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
We are a clinical-stage biotechnology company focused on leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Nitric oxide plays a vital role in the natural immune system response against microbial pathogens and is a critical regulator of inflammation. Our ability to harness nitric oxide and its multiple mechanisms of action has enabled us to create a platform with the potential to generate differentiated product candidates. The two key components of our nitric oxide platform are our proprietary Nitricil technology, which drives the creation of new chemical entities, or NCEs, and our topical formulation science, both of which we use to tune our product candidates for specific indications. We believe that the ability to deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to improve patient outcomes in a variety of diseases. ... More ...
Nasdaq Official Price
Dec. 14, 2018
Dec. 14, 2018